Real Time
BOERSE MUENCHEN
20:43:05 01-07-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
4,52
EUR
|
0,00%
|
|
+7,11%
|
-14,72%
|
Fiscaal tijdperk: december |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
25.172
|
22.635
|
31.941
|
35.470
|
30.420
|
-
|
-
|
Bedrijfswaarde
1 |
22.680
|
20.843
|
31.716
|
36.896
|
32.130
|
30.824
|
30.126
|
K/w-verhouding
|
-19,4
x
|
-21
x
|
-26,7
x
|
17,4
x
|
-67,2
x
|
132
x
|
24,7
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
-
|
100
x
|
38,1
x
|
7,84
x
|
11,6
x
|
7,35
x
|
5,03
x
|
Bedrijfswaarde/omzet
|
-
|
92,4
x
|
37,9
x
|
8,15
x
|
12,3
x
|
7,45
x
|
4,98
x
|
Bedrijfswaarde/EBITDA
|
-17,6
x
|
-16
x
|
-25,9
x
|
16,8
x
|
-113
x
|
60,2
x
|
20,3
x
|
Bedrijfswaarde/FCF
|
-19,3
x
|
-12,1
x
|
-15,5
x
|
23,2
x
|
-47,2
x
|
-582
x
|
25,8
x
|
FCF Yield
|
-5,17%
|
-8,24%
|
-6,44%
|
4,3%
|
-2,12%
|
-0,17%
|
3,88%
|
Price to Book
|
6,31
x
|
7,16
x
|
11,9
x
|
7,53
x
|
6,53
x
|
5,84
x
|
4,65
x
|
Aantal aandelen (in duizenden)
|
787.057
|
817.057
|
841.057
|
841.057
|
865.857
|
-
|
-
|
Referentieprijs
2 |
31,98
|
27,70
|
37,98
|
42,17
|
35,13
|
35,13
|
35,13
|
Datum van publicatie
|
31/03/21
|
30/03/22
|
15/03/23
|
18/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
-
|
225,6
|
837,7
|
4.526
|
2.620
|
4.138
|
6.044
|
EBITDA
1 |
-1.290
|
-1.302
|
-1.225
|
2.191
|
-285,5
|
512,1
|
1.482
|
Bedrijfsresultaat (EBIT)
1 |
-1.313
|
-1.351
|
-1.331
|
2.049
|
-458
|
279,3
|
1.313
|
Operationele Marge
|
-
|
-598,89%
|
-158,92%
|
45,26%
|
-17,48%
|
6,75%
|
21,72%
|
Resultaat voor belastingen (EBT)
1 |
-1.321
|
-1.258
|
-1.422
|
1.943
|
-484,5
|
240,8
|
1.443
|
Nettowinst (verlies)
1 |
-1.177
|
-1.075
|
-1.168
|
2.028
|
-432,4
|
221,6
|
1.210
|
Nettomarge
|
-
|
-476,42%
|
-139,48%
|
44,81%
|
-16,5%
|
5,36%
|
20,03%
|
WPA
2 |
-1,650
|
-1,320
|
-1,420
|
2,420
|
-0,5232
|
0,2654
|
1,424
|
Free Cash Flow
1 |
-1.173
|
-1.717
|
-2.043
|
1.588
|
-681,1
|
-52,96
|
1.168
|
FCF-marge
|
-
|
-761,15%
|
-243,88%
|
35,09%
|
-25,99%
|
-1,28%
|
19,32%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
72,48%
|
-
|
-
|
78,76%
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
78,31%
|
-
|
-
|
96,45%
|
Dividend per aandeel
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
31/03/21
|
30/03/22
|
15/03/23
|
18/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021 S1
|
2021 S2
|
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
---|
Omzet
1 |
-
|
97,03
|
-
|
674,5
|
3.677
|
849,4
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-
|
-
|
-
|
-
|
2.482
|
-433,9
|
Operationele Marge
|
-
|
-
|
-
|
-
|
67,51%
|
-51,09%
|
Resultaat voor belastingen (EBT)
1 |
-
|
-812
|
-
|
-730,3
|
2.490
|
-547
|
Nettowinst (verlies)
1 |
-424,9
|
-
|
-630,4
|
-538
|
2.525
|
-496,7
|
Nettomarge
|
-
|
-
|
-
|
-79,75%
|
68,67%
|
-58,48%
|
WPA
|
-0,5200
|
-
|
-0,7700
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
23/09/21
|
30/03/22
|
23/08/22
|
15/03/23
|
29/08/23
|
18/03/24
|
Fiscaal tijdperk: december |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
1.425
|
1.710
|
404
|
-
|
Nettokaspositie
1 |
2.492
|
1.792
|
225
|
-
|
-
|
-
|
294
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
0,6505
x
|
-5,991
x
|
0,7893
x
|
-
|
Free Cash Flow
1 |
-1.173
|
-1.717
|
-2.043
|
1.588
|
-681
|
-53
|
1.168
|
ROE (netto-inkomsten/eigen vermogen)
|
-74%
|
-33,9%
|
-40,3%
|
55,4%
|
-8,69%
|
5,1%
|
19,8%
|
ROA (netto-inkomsten/totale activa)
|
-42,6%
|
-24,8%
|
-22,7%
|
27,6%
|
-3,96%
|
3,6%
|
11,8%
|
Totale activa
1 |
2.765
|
4.331
|
5.151
|
7.339
|
10.925
|
6.159
|
10.276
|
Nettoactief per aandeel
2 |
5,060
|
3,870
|
3,200
|
5,600
|
5,380
|
6,010
|
7,550
|
Cashflow per aandeel
2 |
-0,9800
|
-1,230
|
-1,500
|
2,950
|
-0,3000
|
0,4300
|
1,650
|
Capex
1 |
556
|
716
|
802
|
879
|
356
|
308
|
285
|
Capex/omzet
|
-
|
317,39%
|
95,8%
|
19,43%
|
13,59%
|
7,43%
|
4,72%
|
Datum van publicatie
|
31/03/21
|
30/03/22
|
15/03/23
|
18/03/24
|
-
|
-
|
-
|
Laatste slotkoers
35,13
CNY Gemiddelde koersdoel
55,14
CNY Spread / Gemiddelde doel +56,95% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| +15,77% | 121 mld. | | +19,72% | 113 mld. | | +17,47% | 26,02 mld. | | -25,33% | 19,39 mld. | | -19,51% | 15,91 mld. | | -19,31% | 15,09 mld. | | -46,87% | 15,06 mld. | | +62,83% | 14,93 mld. | | +6,39% | 13,85 mld. |
Biotherapeutische geneesmiddelen
|